A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04)

Karim Fizazi; Aline Maillard; Nicolas Penel; G. Baciarello; Djelila Allouache; Gedske Daugaard; A. van de Wouw; G. Soler; Élodie Vauléon; L. Chaigneau; René A. J. Janssen; F. Losa Gaspà; Rafael Morales‐Barrera; Carmen Balañá; Diégo Tosi; Bruno Chauffert; Claudia Schnabel; Géraldine Martineau; S. Culine; Isabelle Borget

doi:10.1093/annonc/mdz394

A phase III trial of empiric chemotherapy with cisplatin and gemcitabine or systemic treatment tailored by molecular gene expression analysis in patients with carcinomas of an unknown primary (CUP) site (GEFCAPI 04) | Litlas